Literature DB >> 27603496

Six Germline Genetic Variations Impair the Translesion Synthesis Activity of Human DNA Polymerase κ.

Jae-Kwon Kim1, Mina Yeom1, Jin-Kyung Hong1, Insil Song1, Young-Sam Lee2, F Peter Guengerich3, Jeong-Yun Choi1.   

Abstract

DNA polymerase (pol) κ efficiently catalyzes error-free translesion DNA synthesis (TLS) opposite bulky N2-guanyl lesions induced by carcinogens such as polycyclic aromatic hydrocarbons. We investigated the biochemical effects of nine human nonsynonymous germline POLK variations on the TLS properties of pol κ, utilizing recombinant pol κ (residues 1-526) enzymes and DNA templates containing an N2-CH2(9-anthracenyl)G (N2-AnthG), 8-oxo-7,8-dihydroguanine (8-oxoG), O6-methyl(Me)G, or an abasic site. In steady-state kinetic analyses, the R246X, R298H, T473A, and R512W variants displayed 7- to 18-fold decreases in kcat/Km for dCTP insertion opposite G and N2-AnthG, with 2- to 3-fold decreases in DNA binding affinity, compared to that of the wild-type, and further showed 5- to 190-fold decreases in kcat/Km for next-base extension from C paired with N2-AnthG. The A471V variant showed 2- to 4-fold decreases in kcat/Km for correct nucleotide insertion opposite and beyond G (or N2-AnthG) compared to that of the wild-type. These five hypoactive variants also showed similar patterns of attenuation of TLS activity opposite 8-oxoG, O6-MeG, and abasic lesions. By contrast, the T44M variant exhibited 7- to 11-fold decreases in kcat/Km for dCTP insertion opposite N2-AnthG and O6-MeG (as well as for dATP insertion opposite an abasic site) but not opposite both G and 8-oxoG, nor beyond N2-AnthG, compared to that of the wild-type. These results suggest that the R246X, R298H, T473A, R512W, and A471V variants cause a general catalytic impairment of pol κ opposite G and all four lesions, whereas the T44M variant induces opposite lesion-dependent catalytic impairment, i.e., only opposite O6-MeG, abasic, and bulky N2-G lesions but not opposite G and 8-oxoG, in pol κ, which might indicate that these hypoactive pol κ variants are genetic factors in modifying individual susceptibility to genotoxic carcinogens in certain subsets of populations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27603496      PMCID: PMC5116392          DOI: 10.1021/acs.chemrestox.6b00244

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  59 in total

1.  Crystal structure of the catalytic core of human DNA polymerase kappa.

Authors:  Sacha N Uljon; Robert E Johnson; Thomas A Edwards; Satya Prakash; Louise Prakash; Aneel K Aggarwal
Journal:  Structure       Date:  2004-08       Impact factor: 5.006

2.  Elevated mutation rates in the germline of Polkappa mutant male mice.

Authors:  Karen L-A Burr; Susana Velasco-Miguel; Venkata S Duvvuri; Lisa D McDaniel; Errol C Friedberg; Yuri E Dubrova
Journal:  DNA Repair (Amst)       Date:  2006-05-30

3.  DNA polymerase kappa is specifically required for recovery from the benzo[a]pyrene-dihydrodiol epoxide (BPDE)-induced S-phase checkpoint.

Authors:  Xiaohui Bi; Damien M Slater; Haruo Ohmori; Cyrus Vaziri
Journal:  J Biol Chem       Date:  2005-04-06       Impact factor: 5.157

4.  Somatic Mutations in Catalytic Core of POLK Reported in Prostate Cancer Alter Translesion DNA Synthesis.

Authors:  Santosh Yadav; Sudurkia Mukhopadhyay; Muralidharan Anbalagan; Nick Makridakis
Journal:  Hum Mutat       Date:  2015-06-25       Impact factor: 4.878

5.  Localisation of human Y-family DNA polymerase kappa: relationship to PCNA foci.

Authors:  Tomoo Ogi; Patricia Kannouche; Alan R Lehmann
Journal:  J Cell Sci       Date:  2004-12-15       Impact factor: 5.285

Review 6.  Causes and consequences of replication stress.

Authors:  Michelle K Zeman; Karlene A Cimprich
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

7.  Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links.

Authors:  Irina G Minko; Michael B Harbut; Ivan D Kozekov; Albena Kozekova; Petra M Jakobs; Susan B Olson; Robb E Moses; Thomas M Harris; Carmelo J Rizzo; R Stephen Lloyd
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

8.  Comparison of predicted and actual consequences of missense mutations.

Authors:  Lisa A Miosge; Matthew A Field; Yovina Sontani; Vicky Cho; Simon Johnson; Anna Palkova; Bhavani Balakishnan; Rong Liang; Yafei Zhang; Stephen Lyon; Bruce Beutler; Belinda Whittle; Edward M Bertram; Anselm Enders; Christopher C Goodnow; T Daniel Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-12       Impact factor: 11.205

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

10.  Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants.

Authors:  Wenqing Fu; Timothy D O'Connor; Goo Jun; Hyun Min Kang; Goncalo Abecasis; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; David Altshuler; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Joshua M Akey
Journal:  Nature       Date:  2012-11-28       Impact factor: 49.962

View more
  3 in total

1.  Characterization of Nine Cancer-Associated Variants in Human DNA Polymerase κ.

Authors:  Nicole M Antczak; Alice R Walker; Hannah R Stern; Emmett M Leddin; Carl Palad; Timothy A Coulther; Rebecca J Swett; G Andrés Cisneros; Penny J Beuning
Journal:  Chem Res Toxicol       Date:  2018-07-30       Impact factor: 3.739

2.  Three Human Pol ι Variants with Impaired Polymerase Activity Fail to Rescue H2O2 Sensitivity in POLI-Deficient Cells.

Authors:  Mina Yeom; Jin-Kyung Hong; Jae-Kwon Kim; F Peter Guengerich; Jeong-Yun Choi
Journal:  Chem Res Toxicol       Date:  2020-07-23       Impact factor: 3.973

Review 3.  Mammalian DNA Polymerase Kappa Activity and Specificity.

Authors:  Hannah R Stern; Jana Sefcikova; Victoria E Chaparro; Penny J Beuning
Journal:  Molecules       Date:  2019-08-01       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.